FRANKFURT (Reuters) - Weitz & Luxenberg said on Wednesday it and other law firms reached a settlement with Bayer (OTC:BAYRY) on behalf of almost one hundred thousand Americans who had been diagnosed with cancer after exposure to Monsanto (NYSE:MON)'s Roundup weedkiller.
The German drugs and pesticides group is keen to draw a line under the legal dispute over Roundup and other glyphosate-based weedkillers, which it inherited via its $63 billion takeover of Monsanto in 2018.
Bayer was not immediately available for comment.